Project Grant R21HD121503
- The University of Washington was awarded a $734,151 Project Grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant will fund a 5-year research study to examine the impact of HIV and toxic metal exposures on neurodevelopment outcomes in school-age children in East and Southern Africa. The key products and services to be delivered under this grant...
- This $293,550 Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), is funding research to investigate the effect of inherited maternal cells on BCG-specific T cell responses in HIV-exposed and unexposed infants. The award supports a study hypothesizing that reduced transmission of maternal microchimerism in utero may be a mechanism...
- The National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, awarded a $615,478 Project Grant to the University of Washington on June 18, 2025. The grant is part of the Child Health and Human Development Extramural Research program (CFDA 93.865) and aims to optimize neuroprotective strategies for hypoxic-ischemic encephalopathy (HIE) in low- and middle-income countries. The University of Washington will develop...
- This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $588,566 to the University of Maryland, Baltimore to conduct a cross-disciplinary study on the long-term neurodevelopmental and school readiness impacts of in-utero HIV exposure on children in Sub-Saharan Africa. The research aims to establish a core team of investigators who can...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $690,538 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Washington for the project "EXPANDING ACCESS AND IMPACT OF TUBERCULOSIS PREVENTIVE THERAPY: COMMUNITY-FRIENDLY DELIVERY AND MONITORING OF TPT TO IMPROVE UPTAKE AND REDUCE TB TRANSMISSION." The project aims to explore new, person-friendly models of tuberculosis preventive therapy (TPT) delivery to...
- The National Institute of Child Health and Human Development (NICHD) awarded a $2,207,322 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the University of Nebraska Medical Center to develop dose flexible, ultra-long-acting prodrug formulations for antiretroviral therapy (ART) in pediatric HIV patients. The goal is to create a complete every 6-month integrase strand transfer inhibitor (INSTI)-based ART regimen, including bictegravir,...
- This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research Federal Grant Program (CFDA 93.865) aims to develop a non-invasive bioimaging tool to track antiretroviral-induced neurodevelopmental adverse events during gestation in a rodent model. The $844,250 award to the Board of Regents of the University of Nebraska's University of Nebraska Medical Center (UNMC) division...
- The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded a $232,500 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to The Johns Hopkins University. The grant supports research to investigate the virologic determinants that lead to long-term antiretroviral therapy-free control in a subset of infants infected with HIV-1 in utero. Key research activities include: Creating infectious molecular clones...
- The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research Federal Grant Program (CFDA 93.865), awarded a $1,463,500 Project Grant to The Regents of the University of California, San Francisco (UCSF) to conduct a randomized controlled trial of an agricultural livelihood intervention to improve maternal and newborn health and nutrition in Kenya. The grant, awarded on January 17, 2025, will fund a...
- This $499,140 Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will fund the "TSEPAMO NEXT GENERATION: OPTIMIZING HIV TREATMENT AND PREVENTION STRATEGIES FOR PREGNANT WOMEN IN BOTSWANA" research study. The study has two key aims: 1) to assess the safety and efficacy of two-drug antiretroviral therapy (ART) with...
The University of Washington received a $233,250 Project Grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant, awarded on September 25, 2025, will be used to evaluate the extent and outcomes of isoniazid (INH) exposure during pregnancy among infants born to women living with HIV-tuberculosis (TB) in high-burden settings. The project will quantify maternal and infant in-utero INH exposure using hair sample analysis, focusing on women receiving INH as TB preventive therapy (TPT) during pregnancy, including those on newer dolutegravir (DTG)-based antiretroviral therapy (ART) regimens. This data will help inform prenatal INH policies for pregnant women living with HIV in settings with high TB prevalence. The ultimate completion date for the project is August 31, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $233.3k | 9/25/25 |